Cited 0 times in
Randomized phase II study of nalicap (nalIRI/capecitabine) compared to NAPOLI ( nal-IRI/5F-U/LV) in gemcitabine-pretreated advanced pancreatic cancer: Trial-in-progress
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.